ArticleMolecular therapy. Nucleic acids2026
DNA oligonucleotides encoding suppressor tRNA induce readthrough of premature termination codon.
Article in Molecular therapy. Nucleic acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonsense mutation is a type of DNA mutation that converts sense codon in mRNA into premature termination codon (PTC), causing protein truncation. Recent studies have revealed that suppressor tRNAs, which read the stop codon instead of the natural codon and encode the desired amino acid, induce PTC readthrough and restore protein function. However, RNA is prone to degradation, presenting numerous challenges for tissue delivery in gene therapy. Here, we show that DNA oligonucleotides encoding suppressor tRNA sequences but without additional Pol III promoters induce PTC readthrough in cultured cells. Sequence-matched microRNAs specifically inhibited PTC readthrough mediated by the transfected DNA oligonucleotides. Furthermore, treatment with an RNA Pol III inhibitor significantly reduced DNA oligonucleotide-mediated PTC readthrough. These findings support the conclusion that functional suppressor tRNAs are transcribed from DNA oligonucleotides in cultured cells. These results suggest that DNA oligonucleotides hold potential as a novel therapeutic approach enabling suppressor tRNA expression for nonsense mutation repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.